Parkinson's disease. Second of two parts.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9770561.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
At no time in the past have the basic and clinical sciences applied to Parkinson's disease been so active. Experimental therapies under study at present promise to improve on the limitations of existing treatments. Future progress in understanding the causation and pathogenesis of the disorder will permit the development of new treatments that will slow, halt, or even reverse the currently inexorable progressive course of Parkinson's disease.
Medical subject headings
- Antiparkinson Agents
- Levodopa
- Parkinson Disease